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http://dx.doi.org/10.1016/j.pedneo.2
1875-9572/Copyrightª 2016, Taiwan P
NC-ND license (http://creativecommoBackground: Ventilator-associated pneumonia (VAP) is one of the most common healthcare-
associated infections among ventilated patients. The aim of this study was to determine the
clinical characteristics and risk factors for the development of VAP in intubated low birth
weight (LBW) neonates in a neonatal intensive care unit.
Methods: LBW infants (<2.5 kg) admitted to the neonatal intensive care unit of Kaohsiung
Medical University Hospital from January 2005 to December 2009 were enrolled. We retro-
spectively analyzed perinatal and neonatal data of the enrolled intubated LBW infants by
chart review.
Results: Six hundred and five LBW infants were analyzed. One hundred and fourteen of the
infants were intubated for >48 hours, 15 (13.2%) of whom had VAP. Of these 15 patients, the
average age at onset of VAP was 24.0  11.2 days, the average postmenstrual age was
30.6  1.8 weeks, and the mean gestational age was 27.1  2.3 weeks, which was signifi-
cantly lower than the mean gestational age in the group without VAP (30.2  3.5 weeks).
The mean birth body weight was 944.4  268.4 g in the VAP group and 1340.1  455.4 g in
the group without VAP (p < 0.001). Longer duration of intubation (odds ratio: 1.35, 95% con-
fidence interval: 1.12e1.62) and parenteral nutrition (odds ratio: 1.32, 95% confidence inter-
val: 1.14e1.51) were found in the VAP group after adjusting for gestational age and birth
weight.
Conclusion: VAP was a problem for the LBW infants with intubation for >48 hours in
our neonatal intensive care unit. VAP most frequently occurred at a postmenstrual age of
30e32 weeks in this study. Longer duration of tube placement and parenteral nutrition wereof Pediatrics, Kaohsiung Medical University Hospital, Number 100, Tzyou 1st Road, Kaohsiung City
org.tw (H.-L. Chen).
e P-L, et al., Ventilator-Associated Pneumonia in Low Birth Weight Neonates at a Neonatal Intensive
onal Study, Pediatrics and Neonatology (2016), http://dx.doi.org/10.1016/j.pedneo.2015.10.014
015.10.014
ediatric Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-
ns.org/licenses/by-nc-nd/4.0/).
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Care Unit: A Retrospective Observatfound in the VAP group. Early removal of the endotracheal tube and adequate enteral nutri-
tion may decrease the occurrence of VAP in LBW infants.
Copyright ª 2016, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Ventilator-associated pneumonia (VAP) is a common and
severe complication of critical illnesses in intensive care
units (ICUs). It is associated with longer durations of hos-
pital and ICU stay and high rates of morbidity and mortality
in patients in an ICU. Several studies have reported on VAP
in pediatric patients; however, few studies have focused on
neonates, especially those with a birth weight <2.5 kg (low
birth weight, LBW).1e5 The leading causes of death in ne-
onates are disorders related to short gestation and LBW.6
Respiratory distress syndrome is the most common respi-
ratory diagnosis in preterm LBW neonates requiring respi-
ratory support.7 In addition, the incidence of respiratory
distress syndrome has been reported to be higher among
infants with a lower gestational age and lower birth
weight.8 To rescue these smaller preterm infants, respira-
tory support including intubation and the use of mechanical
ventilation is crucial after birth. Neonatal pneumonia is
also a common cause of respiratory distress in neonates,
and it also necessitates mechanical ventilation after birth.9
Although the survival of preterm LBW neonates has
improved with improvements in the techniques of neonatal
mechanical ventilation and advancing neonatal care, a
longer duration of mechanical ventilation can still lead to
respiratory morbidity including VAP and bronchopulmonary
dysplasia.10,11 Therefore, VAP in preterm infants, and
especially LBW infants, is an important issue.
To evaluate the condition of VAP in our neonatal ICU
(NICU), we enrolled intubated LBW infants undergoing
mechanical ventilation for >48 hours from January 2005 to
December 2009. The aim of this study was to determine the
clinical characteristics and risk factors for the development
of VAP in LBW neonates in our NICU.
2. Methods
2.1. Patients
From January 2005 to December 2009, all intubated LBW
infants (birth weight <2.5 kg) admitted to the NICU of
Kaohsiung Medical University Hospital were enrolled. We
retrospectively analyzed perinatal and neonatal data of the
intubated LBW infants undergoing mechanical ventilation
for >48 hours. The perinatal data included gestational age,
body weight, percentage of small for gestational age, Apgar
score at 1 and 5 minutes, National Therapeutic Intervention
Scoring System (NTISS) scores, endotracheal intubation,
and length of hospital stay. Small for gestational age was
defined as a weight below the 10th percentile for the
gestational age.12 Death was regarded as death beforee P-L, et al., Ventilator-Associate
ional Study, Pediatrics and Neonadischarge from the hospital. The NTISS score was recorded
within 48 hours of admission. The neonates intubated for
>48 hours were divided into two groups: those with VAP
(VAP group) and those without VAP (no-VAP group). Clinical
symptoms, laboratory findings, radiological signs, and
microbiological findings of the VAP patients were recorded.
The diagnosis of VAP was made on the basis of new or
progressive respiratory symptoms and infiltrates/patches
on chest X ray. According to Centers for Disease Control and
Prevention (CDC) diagnostic criteria for VAP in infants
younger than 1 year, the diagnosis should be based on all of
the three items of radiologic signs, clinical signs and
symptoms, and microbiological findings.13 Tracheal aspirate
in each enrolled patient was obtained for microbiological
data. VAP was documented from the chart review. X rays
were interpreted by the authors.
2.2. Statistical analysis
Categorical data are presented as numbers (%) and
continuous data as the mean  standard deviation. The
characteristics of the patients with and without VAP were
compared using Student t tests for numerical data and c2
tests for categorical data. Univariate and multivariate an-
alyses were performed to explore the risk factors related to
VAP. JMP version 10 (SAS Institute Inc., Cary, NC, USA) was
used for all statistical analyses. The level of statistical
significance was defined as p < 0.05.
2.3. Ethics
This study was approved by the Institutional Review Board
of Kaohsiung Medical University Hospital: KMUHIRBe
20140028.
3. Results
From January 2005 to December 2009, 662 LBW neonates
were admitted to the NICU of Kaohsiung Medical University
Hospital. One hundred and fifteen (17.4%) of the LBW neo-
nates required intubation after birth; one of whom was
excluded from this study because of an intubation period
<48 hours. Of the remaining 114 patients who received
48 hours ofmechanical ventilation, 15 patients (13.2%)met
the criteria of VAP and had received antibiotics for at least
7 days. The characteristics of the intubated LBW neonates
with and without VAP are detailed in Table 1. The mean
gestational agewas 27.1 2.3weeks in the VAP group, which
was significantly lower than that in the no-VAP group
(30.2  3.5 weeks). The mean birth body weight was
944.4  268.4 g in the VAP group compared withd Pneumonia in Low Birth Weight Neonates at a Neonatal Intensive
tology (2016), http://dx.doi.org/10.1016/j.pedneo.2015.10.014
Table 1 Characteristics of the intubated LBW neonates with and without VAP.
Characteristics VAP (n Z 15) No-VAP (n Z 99) p
Male*, n (%) 10 (66.7) 57 (57.6) 0.505
Gestational age,y weeks 27.1  2.3 30.2  3.5 <0.001
Birth body weight,y g 944.4  268.4 1340.1  455.4 <0.001
Birth weight group* <0.00
1501e2500 g, n (%) 0 (0) 35 (35.4)
1001e1500 g, n (%) 4 (3.7) 40 (40.4)
<1001 g, n (%) 11 (73.3) 24 (24.2)
Apgar score at 1 miny 5.5  1.4 5.1  1.9 0.336
Apgar score at 5 miny 6.8  1.3 6.9  1.8 0.721
NTISS scorey 24.3  6.0 20.6  5.7 0.024
Patent ductus arteriosus,* n (%) 14 (93.3) 71 (71.7) 0.073
Breast feeding,* n (%) 14 (93.3) 87 (87.9) 0.536
Duration of intubation, dy 58.7  39.6 12.6  19.2 <0.001
PICC, n (%)* 15 (100) 90 (90.9) 0.224
TPN, n (%)* 15 (100) 85 (85.9) 0.120
Duration of TPN,y d 85.3  45.9 30.9  25.9 <0.001
Length of stay in hospital,y d 107.3  55.2 44.8  32.9 <0.001
Death,* n (%) 2 (13.3) 17 (17.2) 0.710
Data are presented as n (%) or mean  standard deviation.
LBW Z low birth weight; NTISS Z National Therapeutic Intervention Scoring System; PICC Z peripheral inserted central catheter;
TPN Z total parenteral nutrition; VAP Z ventilator-associated pneumonia.
* c2 test.
y t test.

















1 853 25þ3 26 29þ1 94
2 695 27þ3 12 29þ1 33
3 541 27þ3 21 30þ3 34
4 717 25þ6 26 29þ4 89
5 1420 29þ5 11 31þ2 3
6 850 25þ4 42 31þ4 44
7 1280 29 17 31þ3 160
8 880 26þ2 33 31 31
9 940 26þ2 14 28þ2 109
10 810 27 44 33þ2 41
11 1000 25þ5 20 28þ4 36
12 880 26 37 31þ2 47
13 1470 33þ2 7 34þ2 49
14 1100 28 27 31þ6 39
15 730 24þ5 23 28 71
BBW Z birth body weight; GA Z gestational age;
PMA Z postmenstrual age; VAP Z ventilator-associated
pneumonia.
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patients with VAP, 11 (73.3%) weighed <1001 g. There were
no significant differences in Apgar scores at 1 and 5 minutes
between the two groups. The VAP group had a significantly
higher NTISS score than the no-VAP group (24.3  6.0 vs.
20.6  5.7, p Z 0.024). The rates of breast feeding, use of
peripheral inserted central catheters, and use of total
parenteral nutrition (TPN) were similar in both groups.
However, the duration of TPN was longer in the VAP group
(85.3  45.9 d vs. 30.9  25.9 d, p < 0.001). The VAP group
also had a significantly longer duration of intubation
(58.7  39.6 d vs. 12.6  19.2 d, p < 0.001) and length of
hospital stay comparedwith theno-VAP group (107.355.2 d
vs. 44.8 32.9 d,p< 0.001). Themortality ratewas similar in
both groups (13.3% vs. 17.2%, pZ 0.710).
Table 2 shows the postnatal and postmenstrual age (PMA)
at the onset of VAP, and the duration of mechanical venti-
lation of the 15 infantswith VAP. Themean postnatal age and
PMA at the onset of VAP in these 15 LBW neonates were
24.0  11.2 days and 30.6  1.8 weeks, respectively. Two
patients (Cases 7 and 9) in the VAP group died before
discharge. Their postnatal ages at onset of VAP were 17 days
and 14 days, and they died at 160 days and 109 days of age,
respectively. The cause of death in both patients was bron-
chopulmonary dysplasia with pulmonary hypertension.
Table 3 and Table 4 show the clinical characteristics of
the 15 patients with VAP. All of the VAP patients had pos-
itive findings on chest X-ray with deterioration in respira-
tory condition. Endotracheal aspirate was used for
bacterial cultures in all of the patients. Three (20%)
patients were diagnosed based on new or progressive
infiltrates and respiratory symptoms without confirmed
cultured organisms. The most commonly culturedPlease cite this article in press as: Lee P-L, et al., Ventilator-Associate
Care Unit: A Retrospective Observational Study, Pediatrics and Neonapathogens from the remaining 12 patients were Klebsiella
pneumoniae (13.3%) and Burkholderia cepacia (13.3%)
(Table 3). The most prevalent clinical symptoms and lab-
oratory findings were new onset of apnea (n Z 10, 66.7%)
and an elevated C-reactive protein level (>5 mg/L) (nZ 9,
60%) (Table 4). The infection rate was 7.1 pneumonia in-
fections per 1000 ventilator days.d Pneumonia in Low Birth Weight Neonates at a Neonatal Intensive
tology (2016), http://dx.doi.org/10.1016/j.pedneo.2015.10.014
Table 3 Microorganisms recovered from sputum cultures
of 15 LBW infants with VAP.
Organisms n (%)
Klebsiella pneumoniae 2 (13.3)
Burkholderia cepacia 2 (13.3)
Chryseobacterium meningosepticum 1 (6.7)
Enterobacter cloacae 1 (6.7)
Enterococcus 1 (6.7)
Escherichia coli 1 (6.7)
Pseudomonas aeruginosa 1 (6.7)
Serratia marcescens 1 (6.7)
Stenotrophomonas maltophilia 1 (6.7)
Staphylococcus haemolyticus 1 (6.7)
No growth 3 (20)
LBW Z low birth weight; VAP Z ventilator-associated
pneumonia.
Table 4 Clinical symptoms and laboratory findings of 15
LBW infants with VAP.
Clinical symptoms and laboratory findings n (%)
New-onset apnea 10 (66.7)
Elevated CRP (>5 mg/L) 9 (60.0)
Bradycardia (<100 beats/min) 5 (33.3)
Increased respiratory secretion 5 (33.3)
New-onset tachypnea 3 (20.0)
I/T ratio 0.2 2 (13.3)
Thrombocytopenia (<100,000 U/L) 4 (26.7)
Fever (>38C) 1 (6.7)
CRP Z C-reactive protein; I/T Z immature to total neutrophil
ratio; LBW Z low birth weight; VAP Z ventilator-associated
pneumonia.
Table 5 Univariate analysis of factors associated with VAP
in the intubated LBW neonates.
Factors OR 95% CI p
Male, n (%) 1.47 0.48e5.02 0.507
Gestational age, wk 0.69 0.53e0.86 0.003
Birth body weight, g 0.997 0.995e0.999 0.0034
Apgar score at 1 min 1.13 0.84e1.58 0.424
Apgar score at 5 min 0.95 0.71e1.33 0.770
NTISS score 1.11 1.01e1.20 0.028
Patent ductus arteriosus 5.52 1.03e102.4 0.107
Breast feeding 1.93 0.34e36.5 0.542
Duration of intubation, wk 1.43 1.22e1.73 <0.001
Duration of TPN, wk 1.33 1.20e1.60 <0.001
CI Z confidence interval; LBW Z low birth weight;
NTISS Z National Therapeutic Intervention Scoring System;
OR Z odds ratio; TPN Z total parenteral nutrition;
VAP Z ventilator-associated pneumonia.
Table 6 Multivariate logistic regression analysis of factors
associated with VAP in intubated LBW neonates.
Factors Adjusted OR* 95% CI p







*Adjusted OR; gestational age and birth weight were adjusted.
CI Z confidence interval; LBW Z low birth weight;
NTISS Z National Therapeutic Intervention Scoring System;
OR Z odds ratio; TPN Z total parenteral nutrition;
VAP Z ventilator-associated pneumonia.
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using univariate analysis (Table 5). Gender, Apgar score,
and breast feeding were not correlated with VAP, whereas
increasing gestational age and birth weight had significant
effects on lowering the occurrence of VAP. A higher NTISSPlease cite this article in press as: Lee P-L, et al., Ventilator-Associate
Care Unit: A Retrospective Observational Study, Pediatrics and Neonascore was associated with the occurrence of VAP [odds ratio
(OR): 1.11, 95% confidence interval (CI): 1.01e1.20], as
were longer durations of intubation and TPN (OR: 1.43, 95%
CI: 1.22e1.73 and OR: 1.33, 95% CI: 1.20e1.60, respec-
tively). We then performed multivariate analysis to identify
the factors associated with VAP in the intubated LBW ne-
onates. Longer duration of intubation (OR: 1.35, 95% CI:
1.12e1.62) and TPN (OR: 1.32, 95% CI: 1.14e1.51) were
found in the VAP group after adjusting for gestational age
and birth weight (Table 6).4. Discussion
In this study, the incidence of VAP was 13.2% in intubated
LBW infants on the basis of new or progressive infiltrates
and respiratory symptoms, and the VAP rate was 7.1 epi-
sodes per 1000 ventilator days. VAP is a problem for LBW
infants with endotracheal tubes in a NICU, and its diagnosis
remains a challenge. The most significant risk factor related
to VAP was the duration of intubation. Although the post-
natal age at the onset of VAP was variable, we found that
the PMA at onset of VAP was similar.
VAP is often considered to occur after respiratory
deterioration during ventilatory support, but few studies
have demonstrated the timing of the onset of VAP among
premature infants. Tekin et al14 reported that the median
time to a diagnosis of VAP was 32.11  29.3 days after
admission. Our results showed that VAP occurred mainly at
a PMA of 30e32 weeks. Alveoli are present at 32 weeks of
age, and the lungs are capable of respiration because of the
alveolocapillary membrane.15 Entering the alveolar period
may be one of the causes of VAP in smaller preterm infants
receiving mechanical ventilatory support.
Healthcare-associated infections are associated with in-
hospital mortality and morbidity. In addition to bloodstream
and urinary tract infections, VAP is one of the most common
healthcare-associated infections among ventilated patients.
The reported rate of VAP in neonates ranges from 2.7 epi-
sodes to 10.9 episodes per 1000 ventilator days.14,16e20 A
recent report from the International Healthcare-associated
Infection Control Consortium collected data on healthcare-
associated infections from ICUs worldwide from 2007 to
2012.21 The reportedmeanVAPrate in LBW infants at Level III
ICUs was 8.95 episodes per 1000 ventilator days, which isd Pneumonia in Low Birth Weight Neonates at a Neonatal Intensive
tology (2016), http://dx.doi.org/10.1016/j.pedneo.2015.10.014
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rate between 7-day and 14-day ventilator circuit changes,
and found no significant difference (9.66 vs. 8.08 episodes
per 1000 ventilator days). We change the ventilator circuit
every 7 days in our NICU as routine practice, and the rate of
VAP (7.1 episodes per 1000 ventilator days)was slightly lower
than in the study of Kawanishi et al.22
VAP is thought to be associated with lower gestational age
and lower birth weight due to the higher probability of intu-
bation after birth.Geffers et al18 reported 8677 very lowbirth
weight infants from52 neonatology departments inGermany.
They found that 41.4% of the neonates who developed
healthcare-associated infections weighed <1 kg, and that a
lower gestational age was also a risk factor for neonatal
mortality. The NTISS score was designed to evaluate the
severity of neonatal illnesses.23 Our recently published study
demonstrated that theNTISS score at 48 hours can effectively
predictmortality in very lowbirthweight infants.24Hsuetal25
reported bloodstream infections in 793 neonates, and they
found that NTISS scores 23 had a higher risk (OR: 6.61, 95%
CI: 2.40e26.47) of treatment failure in neonatal bacteremia.
In the current study, the NTISS score in the LBW infants with
VAP was significantly higher than in those without VAP. This
suggests that a higher severity of neonatal illness (requiring
intubation) in LBW neonates after admission increases the
possibility of VAP occurring later during hospitalization.
Patent ductus arteriosus (PDA) is a congenital cardiac
condition in which the neonatal ductus arteriosus fails to
close after birth, and preterm infants tend to have a higher
incidence of PDA. Despite advances in the treatment of
PDA, hemodynamic and pulmonary alterations often occur
in patients with PDA, and the need for respiratory support
may be greater in neonates with PDA. Gonzalez et al26 re-
ported a relationship between PDA and infection, and they
found that infection adversely influenced PDA. Although
there was higher percentage of PDA in the VAP group
compared with the no-VAP group in the current study (Table
1), it did not reach statistical significance (p Z 0.073).
Themost commonmicroorganisms contributing toVAPare
Gram-negative bacilli,1,16,27 as also seen in our results. Other
studies have shown that, in addition to Gram-negative bac-
teria, coagulase-negative staphylococci are commonly
involved in VAP, accounting for 13.5e23% of all cases of
VAP.1,16,18,20 Although microbiological findings are essential
to make a diagnosis of VAP according to the CDC diagnostic
criteria for VAP, some authors have found it difficult to
distinguish respiratory infections from colonizers via endo-
tracheal aspirate.28,29 In Germany, Geffers et al17 studied
8677 very low birth weight (VLBW) infants in whom VAP was
diagnosed based on respiratory compromise, radiological
findings and clinical presentation without requiring micro-
biological reports. In our study, three patients were diag-
nosed with VAP based on a deteriorating respiratory
condition, clinical symptoms andnewfindings on chest X-ray.
One review article concluded that the diagnosis of VAP in
pediatric patients was difficult because of the low sensitivity
of qualitative tracheal aspirate cultures, which are most
commonly used in pediatric ICUs.30 In order to be more
applicable to a clinical setting when diagnosing VAP in pedi-
atric patients, Mariki et al31 proposed modified microbio-
logical criteria combining an endotracheal specimen growth
of one or more organisms and moderate/manyPlease cite this article in press as: Lee P-L, et al., Ventilator-Associate
Care Unit: A Retrospective Observational Study, Pediatrics and Neonapolymorphonuclear leukocytes. They found that only 28% of
the 102 patients meeting the inclusion criteria also met both
clinical and radiological CDC criteria for VAP.
Neonatal patients with VAP commonly present with an
unstable temperature, bradycardia, tachycardia, and res-
piratory symptoms.13 In addition to signs of dyspnea, apnea
is more common among neonates with VAP compared with
older children. Apisarnthanarak et al16 reported that hy-
pothermia (79%) and new-onset tachypnea (63%) were the
most common clinical symptoms in extremely preterm ne-
onates. Khattab et al32 compared neonates with and
without VAP, and they found that chest auscultation find-
ings and mucopurulent endotracheal tube secretion
occurred inw80% of the neonates with VAP. In our patients
with VAP, new-onset apnea was the most common clinical
sign. Although apnea is not uncommon, it should be
considered a clue for the diagnosis of VAP in a NICU.
One systemic review showed that pediatric patients with
risk factors including genetic syndrome, steroid therapy,
reintubation, bloodstream infections, prior antibiotic ther-
apy, and bronchoscopy tended to have a higher incidence of
VAP.2 In the neonatal period, the duration of intubation and
previous bloodstream infections were more commonly
associated with VAP. The duration of mechanical ventilation
is reported to be one of themost common risk factors leading
to the occurrence of VAP.2,33e35 In our study, we found longer
duration of intubation and TPN in the VAP group after
multivariate analysis. If the endotracheal tube can be
removed earlier, the risk for VAP is lower. Also, poor nutri-
tional status is associated with difficulty of weaning from
ventilator. We think that durations of intubation and TPN,
rather than just outcome, are important for intubated LBW
infants. Physicians should evaluate the need for intubation
with mechanical ventilation carefully and attempt to
improve the nutritional condition for intubated LBW infants.
Therefore, extubation and introducing enteral feeding as
soon as possible may reduce the risk of VAP. One adult study
demonstrated that enteral feeding may increase the risk of
stomach colonization and lead to a higher incidence of
nosocomial pneumonia.36 However, the early introduction of
parenteral or enteral nutrition has been reported to be well-
tolerated in very preterm infants.37 Early restart or not dis-
continuing enteral feeding may be a strategy to reduce the
occurrence of VAP in intubated LBW neonates.
In conclusion, VAP is a problem for LBW infants with
intubation for >48 hours in our NICU. Longer duration of
intubation and TPN were found in the VAP group. The early
removal of the endotracheal tube and adequate enteral
nutrition may decrease the occurrence of VAP in intubated
LBW neonates.Conflict of interest
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